Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli [Pré-print]

    Zeng, Mei; Xia, Jun; Zong, Zhiyong; Shi, Yi; Ni, Yuxing; Hu, Fupin; Chen, Yijian; Zhuo, Chao; Hu, Bijie; Lv, Xiaoju; Li, Jiabin; Liu, Zhengyin; Zhang, Jing; Yang, Wenjie; Yang, Fan; Yang, Qiwen; Zhou, Hua; Li, Xin; Wang, Jianhua; Li, Yimin; Wang, Minggui.
    The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug-resistant, resulting in limited antimicrobial treatment options and high mortality. A multidisciplinary guideline development group cov...
    Bacterias Gramnegativas/efectos de los fármacos, Carbapenémicos/uso terapéutico, Pseudomonas aeruginosa/efectos de los fármacos, Farmacorresistencia Microbiana, Control de Infección Dental
    Texto completo

    Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli

    Zeng, Mei; Xia, Jun; Shi, YI; Ni, Yuxing; Fupin, Hu; Chen, Yijian; Li, Jiabin; Zhang, Jing; Yang, Fan; Li, Xin; Li, Yimin; Wu, Anhua; Wu, Depei; Qiu, Haibo; Wang, Minggui.
    J Microbiol Inmunol Infect; 23 (), 2023
    The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug-resistant, resulting in limited antimicrobial treatment options and high mortality. A multidisciplinary guideline development group cov...
    Infecciones por Bacterias Gramnegativas/prevención & control, Farmacorresistencia Microbiana, Carbapenémicos/uso terapéutico, Sinergismo Farmacológico
    Texto completo

    Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version)

    Jin, Ying-Hui; Zhan, Qing-Yuan; Peng, Zhi-Yong; Ren, Xue-Qun; Yin, Xun-Tao; Cai, Lin; Yuan, Yu-Feng; Yue, Ji-Rong; Zhang, Xiao-Chun; Yang, Qi-Wen; Ji, Jianguang; Xia, Jian; Li, Yi-Rong; Zhou, Fu-Xiang; Gao, Ya-Dong; Yu, Zhui; Xu, Feng; Tu, Ming-Li; Tan, Li-Ming; Yang, Min; Chen, Fang; Zhang, Xiao-Ju; Zeng, Mei; Zhu, Yu; Liu, Xin-Can; Yang, Jian; Zhao, Dong-Chi; Ding, Yu-Feng; Hou, Ning; Wang, Fu-Bing; Chen, Hao; Zhang, Yong-Gang; Li, Wei; Chen, Wen; Shi, Yue-Xian; Yang, Xiu-Zhi; Wang, Xue-Jun; Zhong, Yan-Jun; Zhao, Ming-Juan; Li, Bing-Hui; Ma, Lin-Lu; Zi, Hao; Wang, Na; Wang, Yun-Yun; Yu, Shao-Fu; Li, Lu-Yao; Huang, Qiao; Weng, Hong; Ren, Xiang-Ying; Luo, Li-Sha; Fan, Man-Ru; Huang, Di; Xue, Hong-Yang; Yu, Lin-Xin; Gao, Jin-Ping; Deng, Tong; Zeng, Xian-Tao; Li, Hong-Jun; Cheng, Zhen-Shun; Yao, Xiaomei; Wang, Xing-Huan.
    Mil. med. res. (Lond.); 7 (41), 2020
    The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are needed. In the ...
    Quimioprevención/métodos, Infecciones por Coronavirus/diagnóstico, Infecciones por Coronavirus/tratamiento farmacológico, Neumonía Viral/diagnóstico, Neumonía Viral/tratamiento farmacológico, Pandemias/prevención & control, Betacoronavirus/efectos de los fármacos, Práctica Clínica Basada en la Evidencia/métodos, Antirretrovirales/uso terapéutico, Lopinavir/uso terapéutico, Cloroquina/uso terapéutico, Receptores de Interleucina-6/uso terapéutico, Hidroxicloroquina/uso terapéutico, Plasma/inmunología
    Texto completo